PMID: 11321933Apr 27, 2001Paper

Immunopathology of immune-mediated (type 1) diabetes

Clinics in Laboratory Medicine
John Marker, Noel Maclaren

Abstract

Immune-mediated diabetes is established as an autoimmune disease, which most often is induced during late infancy or early childhood. Multiple genetic lesions in immune tolerance are required before autoimmunity can be sustained once induced by environmental agents, such as viruses. The diagnostic hallmarks of the disease are the islet autoantibodies, which should be made routinely available to physicians to distinguish this disease from other forms of diabetes. The ability to identify individuals with impending IMD and those at high risk of IMD lends itself to the development of clinical trials to prevent diabetes by immunologic means. We believe that this will soon be possible with the development and use of vaccines.

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Journal of Diabetes and Its Complications
Larissa Avilés-SantaPhilip Raskin
Diabetes Technology & Therapeutics
Karen Lin-SuNoel Maclaren
Journal of Diabetes and Its Complications
Larissa Avilés-SantaPhilip Raskin
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
D D LeeA S Chong
© 2021 Meta ULC. All rights reserved